Related Experiment Video
Updated: Oct 3, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
HemOncAgent: an artificial intelligence system for retrieving structured and narrative oncology knowledge
Abstract:
Oncology knowledge spans structured and unstructured datasets of drugs, regimens, conditions, and identifiers, as well as clinician-authored narratives describing treatment sequencing across disease settings. Answering clinical questions may require accessing both databases and free-text narratives, but existing intelligent retrieval systems favor either relational facts or narrative context. We developed HemOncAgent, an artificial intelligence agent that selects among retrieval tools for the HemOnc knowledge ecosystem: HemOncKB, a curated knowledge graph for pharmacologic relationships, and HemOnc.org , a narrative resource for care pathways. Across structured and narrative benchmarks, HemOncAgent maintained high-fidelity retrieval across question types for which single-source systems showed domain-specific limitations, supporting hybrid tool-based retrieval for more reliable oncology knowledge access.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Tumor Immunotherapy